Team:British Columbia/Human Practices
From 2012.igem.org
(Difference between revisions)
Tingchiawong (Talk | contribs) |
Tingchiawong (Talk | contribs) |
||
Line 4: | Line 4: | ||
==Intellectual Property== | ==Intellectual Property== | ||
+ | [[FAQ]] | ||
*[https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdHdMb09iNDNaYV95TllLazFNTmdCQlE Survey] for other teams | *[https://docs.google.com/spreadsheet/ccc?key=0AngNayWeH_rTdHdMb09iNDNaYV95TllLazFNTmdCQlE Survey] for other teams | ||
**Edit the form by going to Form -> Edit form | **Edit the form by going to Form -> Edit form |
Revision as of 18:55, 22 August 2012
Contents |
Intellectual Property
- Survey for other teams
- Edit the form by going to Form -> Edit form
- Professionals to Consult
- Ask UBC [http://www.uilo.ubc.ca tech transfer office]
- Mike Gold suggested dropping his name to Ian Bell, Technology Transfer Manager for the Life Sciences
- Dr. Andre Marziali, EngPhys Director
- OSLI?
- Ask UBC [http://www.uilo.ubc.ca tech transfer office]
- [http://biobricks.org/bpa/faq/ biobrick agreement]
Previous iGEM work
2011 UQ-australia [http://classic.the-scientist.com/blog/display/53835/ 2010 The Scientist Article] 2010 Caltech [http://igem.uwaterloo.ca/share/Outreach/Human%20Practices%202010/Role%20of%20Biotech%20IPR%20in%202030.pdf 2010 Waterloo] 2007 Edinburgh 2008 UCSF
Community Outreach
OSLI feedback
- Biosafety
- Efficiency
- Environmental